Assay Kits for Lead Discovery and Optimization: Precise & Dependable Solutions
Select the best leads today and accelerate drug development decisions for a successful tomorrow.
With INDIGO’s Assay Kits for Lead Discovery and Lead Optimization applications, you can:
Showing 1–10 of 160 results
-
Cyn Monkey FXR Reporter Assay Kit
Species
Cyn Monkey
Target Type
Nuclear Hormone Receptor
Nuclear Receptor Orthologs
Associated Disease
Cardiovascular, Dermatitis, Dyslipidemia, Kidney Disease, NASH/NAFLD, Obesity, Reproduction
-
Cyn Monkey PGR Reporter Assay Kit
Species
Cyn Monkey
Target Type
Nuclear Hormone Receptor
Nuclear Receptor Orthologs
Associated Disease
Autoimmune, Cancer, Cardiovascular, Dermatitis, Dyslipidemia, Obesity, Osteoporosis, Reproduction
-
Cyn Monkey PPARα Reporter Assay Kit
Species
Cyn Monkey
Target Type
Nuclear Hormone Receptor
Nuclear Receptor Orthologs
Associated Disease
Cancer, Cardiovascular, Dermatitis, Dyslipidemia, NASH/NAFLD, Obesity, Reproduction
-
Cyn Monkey PPARγ Reporter Assay Kit
Species
Cyn Monkey
Target Type
Nuclear Hormone Receptor
Nuclear Receptor Orthologs
Associated Disease
Autoimmune, Cancer, Cardiovascular, Dermatitis, Dyslipidemia, Kidney Disease, NASH/NAFLD, Obesity, Osteoporosis, Reproduction
-
Cyn Monkey PPARδ Reporter Assay Kit
Species
Cyn Monkey
Target Type
Nuclear Hormone Receptor
Nuclear Receptor Orthologs
Associated Disease
Cancer, Dermatitis, Dyslipidemia, NASH/NAFLD, Neurodegenerative, Obesity, Reproduction, Wound Healing
-
Cyn Monkey PXR Reporter Assay Kit
Species
Cyn Monkey
Target Type
Nuclear Hormone Receptor
Nuclear Receptor Orthologs
Associated Disease
Cancer, Cardiovascular, Kidney Disease, NASH/NAFLD, Wound Healing
-
CYP450 Induction Assay Kit
Species
Human
This CYP450 Induction Assay Kit contains optimized reagents for the culturing and treatment of semi-immortalized primary liver cells to assess drug-induced changes in CYP3A4, CYP1A1, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and CYP2E1.
The kit provides two aliquots of semi-immortalized primary liver cells, two cell culture-ready assay plates, optimized Cell Culture Medium for use in all steps of the assay procedure, and three reference compounds (rifampicin, β-naphthoflavone, and CDCA) that activate one or more of the primary xenobiotic-sensing receptors: PXR, CAR, AhR, and FXR. Upon activation, these nuclear receptors modulate the expression of the CYP genes. Also included are seven sets of validated qPCR primers for quantifying drug-induced changes in the expression of CYP3A4, CYP1A1, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and CYP2E1, as well as primers for ACTB.
Please note: This kit does not include reagents or protocols for cell lysis, RNA isolation, cDNA preparation, or qPCR assays.
-
Dog AR Reporter Assay Kit
Species
Dog
Target Type
Nuclear Hormone Receptor
Nuclear Receptor Orthologs
Associated Disease
Autoimmune, Cancer, Cardiovascular, Dyslipidemia, Kidney Disease, NASH/NAFLD, Neurodegenerative, Obesity, Osteoporosis, Reproduction
-
Dog FXR Reporter Assay Kit
Species
Dog
Target Type
Nuclear Hormone Receptor
Nuclear Receptor Orthologs
Associated Disease
Cardiovascular, Dermatitis, Dyslipidemia, Kidney Disease, NASH/NAFLD, Obesity, Reproduction
-
Dog GR Reporter Assay Kit
Species
Dog
Target Type
Nuclear Hormone Receptor
Nuclear Receptor Orthologs
Associated Disease
Autoimmune, Cancer, Cardiovascular, Dermatitis, Dyslipidemia, Kidney Disease, NASH/NAFLD, Obesity, Osteoporosis, Reproduction
Evaluate Drug Candidates’ Safety from Every Angle with INDIGO’s Drug Discovery Assays
Did you know that almost 90% of candidate drugs fail in the first stage of trials?
Your drug lead can reverse the trend!
With INDIGO’s in vitro drug discovery assays, save resources and energy by identifying and characterizing adverse effects and potential risks before your drug candidate progresses further in the drug development process.
Explore INDIGO’s in vitro solutions in the broad categories of Prospective Screens, Safety Pharmacology, and Retrospective Screens, and start focusing your efforts on the best drug leads only.
Prospective Screens
Explore drug-drug interactions with INDIGO’s Nuclear Receptor Profiling and accurately predict the adverse effects of your molecule of interest.
INDIGO Biosciences offers pre-clinical non-GLP Lead Discovery and Lead Optimization services to help researchers confirm the potency and efficacy of their compounds.
Safety Pharmacology
Evaluate your compounds on major receptors with INDIGO’s reporter assay panels to understand their biological and toxicological effects better.
Identify therapeutic agents with the highest selectivity and lowest potential for off-target and unwanted effects with INDIGO’s cell-based receptor assays.
Retrospective Screens
Unexpected results from clinical trials or animal studies? Trouble-shoot with INDIGO's large portfolio of ortholog assays to quickly determine if the response observed in laboratory animals is concordant with humans.
Explore Additional INDIGO’s in vitro Solutions to Improve Drug Discovery
Quickly gain insights into the mechanisms underlying the involvement of key receptors in various diseases with INDIGO’s reporter assays.
Understand a compound's on- and off-target effects and liabilities on overlapping pathways with nuclear receptors functional classifications.